AJOVY

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug AJOVY contains one active pharmaceutical ingredient (API):

1 Fremanezumab
UNII PF8K38CG54 - FREMANEZUMAB

Fremanezumab is a humanised IgG2Δa/kappa monoclonal antibody which selectively binds the calcitonin gene-related peptide (CGRP) ligand and blocks both CGRP isoforms (α- and β-CGRP) from binding to the CGRP receptor. It is believed that prevention of migraine is obtained by its effect modulating the trigeminal system.

Read about Fremanezumab

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AJOVY Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02CD03 N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CD Calcitonin gene-related peptide (CGRP) antagonists
Discover more medicines within N02CD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 537520050008907, 537520050009007
Country: CA Health Products and Food Branch Identifier(s): 02497859
Country: EE Ravimiamet Identifier(s): 1791615, 1791626
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1191358001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 176721, 416492
Country: FR Base de données publique des médicaments Identifier(s): 68696906
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 372224, 386539
Country: HK Department of Health Drug Office Identifier(s): 67139
Country: IE Health Products Regulatory Authority Identifier(s): 89094, 89109
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8464
Country: JP 医薬品医療機器総合機構 Identifier(s): 1190407G1023, 1190407G2020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1087474, 1087475, 1089296, 1089297
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 21711
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100417464
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65973001, W65973002, W68419001, W68419002
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699638955701, 8699638955718
Country: US FDA, National Drug Code Identifier(s): 51759-202, 51759-204
Country: ZA Health Products Regulatory Authority Identifier(s): 54/30.1/0711

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.